Foresite Capital Management IV, LLC

WEST HOLLYWOOD, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$252.0M2026 Q3
Positions6
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Foresite Capital Management IV, LLC reported 6 positions worth $252.0M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: PHVS (60.1%). Biggest move: new buy VCYT ($9.2M).

6 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PHVSPharvaris N.V.$151.6M60.14%4,778,581——+2.3%
▸ 2 CYTKCytokinetics$47.1M18.69%714,695——-19.3%
▸ 3 RLAYRelay Therapeutics$22.6M8.95%1,250,000——-4.3%
▸ 4 EIKNEikon Therapeutics$15.6M6.20%1,943,682——-33.0%
▸ 5 VCYTVeracyte$9.2M3.65%200,000——-47.8%
▸ 6 XENEXenon Pharmaceuticals$6.0M2.36%160,000——+5.6%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Foresite Capital Management IV, LLC hold as of Q3 2026?

Foresite Capital Management IV, LLC reported 6 positions worth $252.0M in its Q3 2026 13F filing. Largest positions: PHVS (60.1%), CYTK (18.7%), RLAY (9.0%), EIKN (6.2%) and VCYT (3.7%).

What did Foresite Capital Management IV, LLC buy in Q3 2026?

New positions: VCYT.

What did Foresite Capital Management IV, LLC sell in Q3 2026?

Sold out entirely: CRNXGBP.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.